Patents by Inventor Laxmikant Datrange

Laxmikant Datrange has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9682953
    Abstract: The present disclosure relates to substituted amide compounds that are inhibitors of Fatty Acid Amide Hydrolase (FAAH), their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions containing them.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: June 20, 2017
    Assignee: ADVINUS THERAPEUTICS LIMITED
    Inventors: Rajendra Kharul, Debnath Bhuniya, Kasim A. Mookhtiar, Umesh Singh, Atul Hazare, Satish Patil, Laxmikant Datrange, Mahesh Thakkar
  • Publication number: 20150065464
    Abstract: The present disclosure relates to substituted amide compounds that are inhibitors of Fatty Acid Amide Hydrolase (FAAH), their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions containing them.
    Type: Application
    Filed: September 21, 2012
    Publication date: March 5, 2015
    Inventors: Rajendra Kharul, Debnath Bhuniya, Kasim A. Mookhtiar, Umesh Singh, Atul Hazare, Satish Patil, Laxmikant Datrange, Mahesh Thakkar
  • Patent number: 8394772
    Abstract: This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: March 12, 2013
    Assignee: Novartis AG
    Inventors: Gregory Raymond Bebernitz, Mark Gary Bock, Debnath Bhuniya, Laxmikant Datrange, Suresh Eknath Kurhade, P. Venkata Palle, Dumbala Srinivas Reddy
  • Publication number: 20120196813
    Abstract: This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.
    Type: Application
    Filed: October 20, 2010
    Publication date: August 2, 2012
    Applicant: NOVARTIS AG
    Inventors: Gregory Raymond Bebernitz, Mark Gary Bock, Debnath Bhuniya, Laxmikant Datrange, Suresh Eknath Kurhade, P. Venkata Palle, Dumbala Srinivas Reddy